These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3772255

  • 1. [Action of ifenprodil tartrate in obliterative arteriopathies of the lower limbs. Combined studies using proximal blood flow and distal transcutaneous oxygen pressure].
    Costes Y, Pruniaux T, Roullier M, Bourgeois F, Flicoteaux H, Neidhardt A, Barale F.
    J Mal Vasc; 1986; 11(3):242-7. PubMed ID: 3772255
    [Abstract] [Full Text] [Related]

  • 2. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
    Ranft J, Heidrich H, Lammersen T.
    J Mal Vasc; 1987; 12(1):78-81. PubMed ID: 3559415
    [Abstract] [Full Text] [Related]

  • 3. [Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled multicenter trial].
    Natali J, Kieny R, Le Bas P, Benhamou M, Molkhou JM.
    Ann Cardiol Angeiol (Paris); 1989 Jun; 38(6):339-42. PubMed ID: 2667444
    [No Abstract] [Full Text] [Related]

  • 4. Transcutaneous oxygen tension (TcPO2) in the testing period of spinal cord stimulation (SCS) in critical limb ischemia of the lower extremities.
    Petrakis IE, Sciacca V.
    Int Surg; 1999 Jun; 84(2):122-8. PubMed ID: 10408282
    [Abstract] [Full Text] [Related]

  • 5. A comparative analysis of transcutaneous oximetry (tcPO2) during oxygen inhalation and leg dependency in severe peripheral arterial occlusive disease.
    Scheffler A, Rieger H.
    J Vasc Surg; 1992 Aug; 16(2):218-24. PubMed ID: 1495145
    [Abstract] [Full Text] [Related]

  • 6. [Double-blind randomized controlled trial of ifenprodil tartrate versus placebo in chronic arterial occlusive disease of the legs at stage II of the Leriche and Fontaine classification].
    Branchereau A, Rouffy J.
    J Mal Vasc; 1995 Aug; 20(1):21-7. PubMed ID: 7745355
    [Abstract] [Full Text] [Related]

  • 7. [Value of measuring transcutaneous oxygen pressure in arterial disease of the legs].
    Becker F, Gabrielle F, Raoux MH, Brenot R, David M.
    Ann Cardiol Angeiol (Paris); 1989 Oct; 38(8):465-72. PubMed ID: 2596817
    [Abstract] [Full Text] [Related]

  • 8. [Transcutaneous oxygen partial pressure and systolic malleolar artery pressure in patients with peripheral arterial occlusive disease. Longitudinal measurements over 14 days].
    Heidrich H, Lammersen T.
    Med Klin (Munich); 1993 Oct 15; 88(10):564-7. PubMed ID: 8272016
    [Abstract] [Full Text] [Related]

  • 9. [Usefulness of transcutaneous oximetry in detection of diabetic microangiopathy in lower limbs].
    Wróblewski T, Starzyńska R.
    Pol Tyg Lek; 1993 Oct 15; 49(16-17):376-8. PubMed ID: 7708557
    [Abstract] [Full Text] [Related]

  • 10. [CO2-induced acral blood flow and the oxygen partial pressure in arterial occlusive disease].
    Hartmann B, Drews B, Bassenge E.
    Dtsch Med Wochenschr; 1991 Oct 25; 116(43):1617-21. PubMed ID: 1935632
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [MR-Imaging of lower leg muscle perfusion].
    Leppek R, Hoos O, Sattler A, Kohle S, Azzam S, Al Haffar I, Keil B, Ricken P, Klose KJ, Alfke H.
    Herz; 2004 Feb 25; 29(1):32-46. PubMed ID: 14968340
    [Abstract] [Full Text] [Related]

  • 14. tcpO2, arterial blood flow and lactate/pyruvate modifications induced by a single dose of naftidrofuryl IV during stage III lower-limb arteriopathies.
    Pointel JP, Thomas C, Mosnier M, Percebois G, Debry G.
    Angiology; 1986 Sep 25; 37(9):647-53. PubMed ID: 3767072
    [Abstract] [Full Text] [Related]

  • 15. 'Pole test' measurements in critical leg ischaemia.
    Paraskevas N, Ayari R, Malikov S, Mollo M, Branchereau P, Hut F, Branchereau A.
    Eur J Vasc Endovasc Surg; 2006 Mar 25; 31(3):253-7. PubMed ID: 16297645
    [Abstract] [Full Text] [Related]

  • 16. [Transcutaneous oxygen pressure (TcPO2): advantages and limitations].
    Got I.
    Diabetes Metab; 1998 Sep 25; 24(4):379-84. PubMed ID: 9805653
    [Abstract] [Full Text] [Related]

  • 17. [O2 inhalation and lowering leg position as a provocation test for transcutaneous measurement of partial oxygen pressure (tcpO2) in advanced peripheral arterial occlusive disease].
    Scheffler A, Rieger H.
    Vasa Suppl; 1991 Sep 25; 33():269-70. PubMed ID: 1788709
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.